SIRT levels are reduced in the tissues of patients with systemic sclerosis, and molecular studies have revealed several mechanisms by which reduced SIRT levels lead to fibrosis, with most attention paid to the regulation of the TGF-β signalling pathway. The gene discussed is TGFB1; the disease is systemic sclerosis.